**About the Editor**

**Shile Huang** focuses on studying the role of mTOR signaling in human diseases, particularly in cancer. Since 1998, he has been studying how mTOR regulates cell survival, cell motility, and lymphangiogenesis; how some small molecules (e.g. curcumin, cryptotanshinone, dihydroartimisinin, and ciclopirox) act as anticancer agents; and how the heavy metal cadmium induces neuronal apoptosis.
